Published in Prostate on May 02, 2011
Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med (2012) 5.49
Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese. Nat Genet (2012) 1.59
Prostate cancer in young men: an important clinical entity. Nat Rev Urol (2014) 1.15
Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Hum Genet (2015) 0.95
Association of RNASEL and 8q24 variants with the presence and aggressiveness of hereditary and sporadic prostate cancer in a Hispanic population. J Cell Mol Med (2013) 0.90
A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status. Genome Biol (2015) 0.90
Sensitization of radio-resistant prostate cancer cells with a unique cytolethal distending toxin. Oncotarget (2014) 0.86
Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection. Cancer Epidemiol Biomarkers Prev (2011) 0.84
Genome-wide association scan for variants associated with early-onset prostate cancer. PLoS One (2014) 0.82
A genetic-based approach to personalized prostate cancer screening and treatment. Curr Opin Urol (2015) 0.79
Influence of age on predictiveness of genetic risk score for prostate cancer in a Chinese hospital-based biopsy cohort. Oncotarget (2015) 0.77
Association between 17q25.3-rs6465657 polymorphism and prostate cancer susceptibility: a meta-analysis based on 19 studies. Onco Targets Ther (2016) 0.75
NUDT11 rs5945572 polymorphism and prostate cancer risk: a meta-analysis. Int J Clin Exp Med (2015) 0.75
Prostate Cancer: How Young is too Young? Curr Urol (2016) 0.75
Interest in genomic SNP testing for prostate cancer risk: a pilot survey. Hered Cancer Clin Pract (2015) 0.75
IPEX Syndrome, FOXP3 and Cancer. J Syndr (2013) 0.75
Assessing the Cumulative Contribution of New and Established Common Genetic Risk Factors to Early-Onset Prostate Cancer. Cancer Epidemiol Biomarkers Prev (2015) 0.75
Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status. Hum Mol Genet (2016) 0.75
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet (2007) 19.18
Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65
Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet (2008) 15.43
Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet (2007) 14.37
A common variant associated with prostate cancer in European and African populations. Nat Genet (2006) 13.47
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet (2007) 12.65
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 10.99
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A (2006) 10.32
Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst (2009) 6.07
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet (2009) 5.13
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst (2007) 4.85
American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection. CA Cancer J Clin (2001) 4.41
Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet (1999) 4.16
Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA). Oncology (Williston Park) (2000) 3.68
Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet (2009) 3.65
Curses--winner's and otherwise--in genetic epidemiology. Epidemiology (2008) 3.19
Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev (2008) 3.05
Sequence variants at 22q13 are associated with prostate cancer risk. Cancer Res (2009) 2.27
A strengthening programme for weak associations. Int J Epidemiol (1988) 2.19
Treatment and survival outcomes in young men diagnosed with prostate cancer: a Population-based Cohort Study. Cancer (2009) 1.89
Association of prostate cancer risk variants with clinicopathologic characteristics of the disease. Clin Cancer Res (2008) 1.74
Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet (2006) 1.70
Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer (2003) 1.42
The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer. Anticancer Res (1994) 0.99
Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer. Clin Cancer Res (2008) 0.99
Genome-wide linkage scan for prostate cancer susceptibility genes in men with aggressive disease: significant evidence for linkage at chromosome 15q12. Hum Genet (2006) 0.96
Hereditary ovarian cancer: a clinicopathological study. Int J Gynecol Pathol (1992) 0.95
Early age of onset in familial breast cancer. Genetic and cancer control implications. Arch Surg (1976) 0.94
Hereditary prostate cancer: clinical characteristics and survival. J Urol (2002) 0.90
Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet (2007) 14.37
A common variant associated with prostate cancer in European and African populations. Nat Genet (2006) 13.47
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A (2006) 10.32
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet (2009) 6.04
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med (2012) 5.49
FKF1 F-box protein mediates cyclic degradation of a repressor of CONSTANS in Arabidopsis. Science (2005) 3.56
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07
Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev (2008) 3.05
Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nat Genet (2011) 3.02
Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am J Epidemiol (2008) 2.79
Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet (2011) 2.70
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet (2012) 2.18
Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell (2009) 2.10
Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum (2012) 2.09
Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes. Diabetes (2008) 2.01
A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet (2005) 1.96
Genetic modifiers of liver disease in cystic fibrosis. JAMA (2009) 1.88
Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol (2003) 1.83
The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc Surg (2008) 1.78
Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet (2006) 1.70
Alcohol consumption and risk of prostate cancer in middle-aged men. Int J Cancer (2005) 1.69
A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet (2011) 1.68
FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. Carcinogenesis (2010) 1.63
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study. Lancet Oncol (2013) 1.61
Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy. J Urol (2012) 1.52
Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. Clin Cancer Res (2009) 1.49
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet (2012) 1.47
Mapping the C. elegans noncoding transcriptome with a whole-genome tiling microarray. Genome Res (2007) 1.46
Combined genome-wide scan for prostate cancer susceptibility genes. J Natl Cancer Inst (2004) 1.44
Genome-wide association study of homocysteine levels in Filipinos provides evidence for CPS1 in women and a stronger MTHFR effect in young adults. Hum Mol Genet (2010) 1.35
Visual disability, visual function, and myopia among rural chinese secondary school children: the Xichang Pediatric Refractive Error Study (X-PRES)--report 1. Invest Ophthalmol Vis Sci (2008) 1.34
Evaluation of 8q24 and 17q risk loci and prostate cancer mortality. Clin Cancer Res (2009) 1.27
Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma. Blood (2009) 1.26
Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men. J Urol (2006) 1.25
Fine-mapping the putative chromosome 17q21-22 prostate cancer susceptibility gene to a 10 cM region based on linkage analysis. Hum Genet (2006) 1.25
Chromosome 17q12 variants contribute to risk of early-onset prostate cancer. Cancer Res (2008) 1.23
Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival. J Clin Oncol (2005) 1.22
Features of the metabolic syndrome and prostate cancer in African-American men. Cancer (2007) 1.22
Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer. Clin Genitourin Cancer (2012) 1.22
Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet (2007) 1.20
Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. Mutat Res (2004) 1.20
Genome-wide linkage scan for prostate cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics Project. Prostate (2006) 1.17
A functional polymorphism in RGS6 modulates the risk of bladder cancer. Cancer Res (2004) 1.16
Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control (2009) 1.15
Elevated risk of prostate cancer among men with Lynch syndrome. J Clin Oncol (2013) 1.14
Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer. Prostate (2008) 1.12
Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study. Prostate (2008) 1.11
Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23. Prostate (2009) 1.10
The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study. J Hum Genet (2008) 1.10
Comparison of ENCODE region SNPs between Cebu Filipino and Asian HapMap samples. J Hum Genet (2007) 1.08
Clonality of sarcomatous and carcinomatous elements in sarcomatoid carcinoma of the prostate. Urology (2006) 1.06
Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men. Urology (2002) 1.05
Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study. Cancer (2014) 1.05
Population-specific coding variant underlies genome-wide association with adiponectin level. Hum Mol Genet (2011) 1.04
Matrix metalloproteinase polymorphisms and bladder cancer risk. Cancer Res (2006) 1.04
Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers. Clin Cancer Res (2004) 1.04
Hereditary prostate cancer as a feature of Lynch syndrome. Fam Cancer (2011) 1.04
Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum (2004) 1.03
Genetic polymorphisms in inflammation pathway genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2011) 1.02
Spectacle acceptance among secondary school students in rural China: the Xichang Pediatric Refractive Error Study (X-PRES)--report 5. Invest Ophthalmol Vis Sci (2008) 1.01
Identifying susceptibility genes for prostate cancer--a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta. Cancer Epidemiol Biomarkers Prev (2005) 1.00
Biomarkers in peripheral arterial disease patients and near- and longer-term mortality. J Vasc Surg (2010) 1.00
A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum (2005) 1.00
Body composition and serum prostate-specific antigen: review and findings from Flint Men's Health Study. Urology (2008) 0.99
The paternal gene of the DDK syndrome maps to the Schlafen gene cluster on mouse chromosome 11. Genetics (2005) 0.99
Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis. Prostate (2006) 0.99
Bayesian inference for the stereotype regression model: Application to a case-control study of prostate cancer. Stat Med (2009) 0.98
Association between Agent Orange and prostate cancer: a pilot case-control study. Urology (2004) 0.98
Risk perception and concern among brothers of men with prostate carcinoma. Cancer (2004) 0.97
Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness. Clin Cancer Res (2007) 0.97
Chromosome 8q24 markers: risk of early-onset and familial prostate cancer. Int J Cancer (2008) 0.97